TSG6 polypeptide fragments for dry eye disease

The present invention relates to the treatment of dry eye disease, and in particular, to (but not limited to) the treatment of dry eye disease with a LINKTSG6 polypeptide. 本发明涉及治疗干眼病，并且具体地涉及(但不限于)用LINK_TSG6多肽治疗干眼病。

Saved in:
Bibliographic Details
Main Authors MILNER CRAIG, OH JOO-YEON, DYE ALAN C
Format Patent
LanguageChinese
English
Published 27.05.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the treatment of dry eye disease, and in particular, to (but not limited to) the treatment of dry eye disease with a LINKTSG6 polypeptide. 本发明涉及治疗干眼病，并且具体地涉及(但不限于)用LINK_TSG6多肽治疗干眼病。
Bibliography:Application Number: CN202080053382